Status:
RECRUITING
Treatment of Negative Symptoms of Schizophrenia by rTMS
Lead Sponsor:
Centre hospitalier de Ville-Evrard, France
Conditions:
Schizophrenia
Negative Symptoms in Schizophrenia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess the effectiveness of rTMS on the negative symptoms of schizophrenia in real conditions. It will also provide a regulatory framework to rTMS treatments under thes...
Eligibility Criteria
Inclusion
- Patient over 18 years of age
- Patient diagnosed with schizophrenia according to the DSM-V criteria (Diagnostic and Statistical Manual of Mental Disorder V5, 2013)
- Stable drug treatment for at least 4 weeks
- Presence or persistence of negative symptoms in the foreground:
- Negative PANSS score ⩾21, positive PANSS score ⩽24
- Patient (or legal representative) willing to participate in the study and having signed an informed consent
- Patient fluent in the French language
- Affiliation to a social security scheme
Exclusion
- Present a contraindication to TMS: intracranial foreign body, unstabilized epilepsy, cochlear implant, pace-maker
- Presence of an unstabilized medical condition
- Pregnant woman
- Woman of childbearing potential and without effective contraception
- Breastfeeding woman
Key Trial Info
Start Date :
June 9 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2028
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT06595654
Start Date
June 9 2023
End Date
March 1 2028
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Etablissement Public de Santé de Ville-Evrard
Neuilly-sur-Marne, France, 93330